follistatin peptide
Selected indexed studies
- Discovery of a follistatin-derived myostatin inhibitory peptide. (Bioorg Med Chem Lett, 2020) [PMID:31874826]
- Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension. (Circulation, 2023) [PMID:37096577]
- Follistatin and follistatin-like 3 in metabolic disorders. (Prostaglandins Other Lipid Mediat, 2023) [PMID:37739334]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Discovery of a follistatin-derived myostatin inhibitory peptide. (2020) pubmed
- Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension. (2023) pubmed
- Follistatin and follistatin-like 3 in metabolic disorders. (2023) pubmed
- Strategic structure-activity relationship study on a follistatin-derived myostatin inhibitory peptide. (2021) pubmed
- Circulating follistatin in relation to energy metabolism. (2016) pubmed
- Activin/follistatin and atherosclerosis--a review. (1998) pubmed
- Follistatin: a multifunctional regulatory protein. (1998) pubmed
- Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis. (2011) pubmed
- The lymphatic endothelium-derived follistatin: activin A axis regulates neutrophil motility in response to Pseudomonas aeruginosa. (2023) pubmed
- Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism. (2023) pubmed